Olfactory Ecto-mesenchymal Stem Cell-derived Exosomes Ameliorate Murine Sjögren's Syndrome Via Suppressing Tfh Cell Response
Overview
Authors
Affiliations
Objectives: To investigate the effect of olfactory ecto-mesenchymal stem cell-derived exosomes (OE-MSC-Exos) on T follicular helper (Tfh) cell response and their implication in treating experimental Sjögrens syndrome (ESS).
Methods: C57BL/6 mice were immunized with salivary glands (SG) proteins to induce ESS mouse model. OE-MSC-Exos were added to the Tfh cell polarization condition, and the proportion of Tfh cells was detected by FCM. The PD-L1 of OE-MSCs was silenced with small interfering RNA to extract siPD-L1-OE-MSC-Exos.
Results: We found that transfer of OE-MSC-Exos markedly attenuated disease progression and reduced Tfh cell response in mice with ESS. In culture, OE-MSC-Exos potently inhibited the differentiation of Tfh cells from naïve T cells. Moreover, OE-MSC-Exos expressed high level of the ligand for the programmed cell death protein 1 (PD-L1), knocking down PD-L1 expression in OE-MSC-Exos significantly decreased their capacity to suppress Tfh cell differentiation in vitro. Consistently, transfer of OE-MSC-Exos with PD-L1 knockdown exhibited profoundly diminished therapeutic effect in ESS mice, accompanied with sustained Tfh cell response and high levels of autoantibody production.
Conclusion: Our results suggest that OE-MSC-Exos may exert their therapeutic effect in ameliorating ESS progression via suppressing Tfh cell response in a PD-L1-dependent manner.
Cui X, Liu L, Duan C, Mao S, Wang G, Li H J Dent Sci. 2025; 20(1):1-14.
PMID: 39873057 PMC: 11762945. DOI: 10.1016/j.jds.2024.10.001.
Targeted Therapy for Severe Sjogren's Syndrome: A Focus on Mesenchymal Stem Cells.
Harrell C, Volarevic A, Arsenijevic A, Djonov V, Volarevic V Int J Mol Sci. 2025; 25(24.
PMID: 39769474 PMC: 11677171. DOI: 10.3390/ijms252413712.
Lin Z, Cai W, Sun Y, Han B, Hu Y, He Z Biophys Rep. 2025; 10(6):403-415.
PMID: 39758422 PMC: 11693500. DOI: 10.52601/bpr.2024.240005.
Wang Z, Yang C, Yan S, Sun J, Zhang J, Qu Z J Inflamm Res. 2024; 17:6827-6846.
PMID: 39372581 PMC: 11451471. DOI: 10.2147/JIR.S488201.